Usio, Inc. - Common Stock (USIO)
1.3300
-0.1000 (-6.99%)
NASDAQ · Last Trade: Apr 6th, 10:50 PM EDT
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · March 26, 2025

USIO stock results show that Usio beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 14, 2024

USIO stock results show that Usio missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 27, 2024

USIO stock results show that Usio missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 15, 2024

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.
Via Benzinga · March 27, 2024

These growth stocks for profit wave offer significant upside potential as investors rotate into more under-the-radar names.
Via InvestorPlace · March 5, 2024

Although tech penny stocks represents a field that’s as speculative as you can get, these ideas happen to enjoy analyst support.
Via InvestorPlace · January 30, 2024

These high-risk, high-reward bets could be at an inflection point before their growth takes off next year.
Via InvestorPlace · December 23, 2023

Tech stocks have been battered, but select oversold plays now offer huge upside potential after massive sell-offs.
Via InvestorPlace · November 17, 2023

Via Benzinga · May 17, 2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
Via Benzinga · November 8, 2023

Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50.
Via Benzinga · March 24, 2023

Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
Via Benzinga · March 8, 2023

Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous Formulation For The Treatment Of Acute Heart Failure."
Via Benzinga · February 22, 2023

Via Benzinga · February 22, 2023

Via Benzinga · December 29, 2022

By David Willey, Benzinga
Via News Direct · December 27, 2022

Ringing the bells for this jolly season? Usio Inc. (NASDAQ: USIO) certainly is, as it got to ring the NASDAQ bell this November. The company believes it has a lot to be making noise about this holiday season.
Via Benzinga · December 21, 2022

Usio (NASDAQ:USIO) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that Usio will report an earnings per share (EPS) of $-0.08.
Via Benzinga · November 8, 2022